This event has ended. Visit the official site or create your own event on Sched.

View analytic
Tuesday, June 28 • 10:30am - 11:30am
#222: Valuing the Clinical Trial Patient

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-16-566-L01-P; CME 1.00; IACET 1.00; RN 1.00

Increasingly, during clinical research development, decisions are made on how to make trials more patient centric, increase patient engagement, and how/when patients will receive their individual research results. In this session, a patient advocate will share perspectives on each of these elements of research design and execution and a bioethicist will share the bioethical considerations for providing individual clinical trial test results to patients. Finally, participants will also hear about a pharmaceutical company's challenges and lessons learned when they decided to thank their clinical trial patients in a national television advertisement.

Learning Objectives

Recognize an increased awareness of clinical trial patients desired benefits from participating in a research study; Describe bioethical considerations when determining whether to provide clinical trial patients with their individual trial test results; Discuss a sponsor company’s experience with thanking clinical trial patients in a television advertisement.


Jane Perlmutter


Bioethical Considerations with the Return of Individual Research Results and Incidental Findings to Clinical Trial Research Participants
Sandra Prucka, MS

Deborah Howe

avatar for Jane Perlmutter

Jane Perlmutter

Founder and President, Gemini Group
Jane Perlmutter is long-term cancer survivor, involved in a wide-range of advocacy which is rooted in her own experiences, but also informed by her formal training and professional experience. She focuses on clinical trials--ensuring the patient voice is considered in selection of research questions, design of trial protocols, and encouraging innovation to increase the speed of developing new treatments. She is also involved in health research... Read More →

avatar for Deborah Howe

Deborah Howe

Associate Director, Vendor Alliance Lead, Bristol-Myers Squibb Company
Deborah Howe is an Associate Director in Vendor Alliance Management in Global Clinical Operations at Bristol-Myers Squibb. Deborah joined Bristol-Myers Squibb in 2005 and has held positions of increasing responsibility in the area of clinical trial recruitment and retention. Deborah graduated from Quinnipiac College with a BS degree in Marketing/Public Relations and completed an accelerated program in Respiratory Therapy.
avatar for Sandra Prucka

Sandra Prucka

Innovation Lead, Eli Lilly and Company
Before coming to Eli Lilly and Company in 2009 I was a clinical genetic counselor and Director of Genetic Counseling Services at the University of Alabama at Birmingham. I have been in the Tailored Therapeutics group at Lilly for 7 years. During this time I completed an internship in our Bioethics group focusing on the ethics of individual results return (IRR). I currently co-chair The Harvard Multiregional Clinical Trials working group to... Read More →

Tuesday June 28, 2016 10:30am - 11:30am
204A Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA